Category: GLOBE-NEWSWIRE

YYForce Unveils “Workforce OS” Robotics Architecture Powered by NVIDIA Physical AI

Integration of NVIDIA Jetson Edge Computing and RTX Accelerators Establishes High-Performance Foundation for Commercial Human-and-Robot Workforces Workforce OS Leverages NVIDIA Project GR00T, Isaac Sim, Isaac ROS, and TensorRT to Accelerate Sim-to-Real Deployments Across Enterprise Hospitality with Unitree Humanoid Robotics SINGAPORE, Oct. 21, 2026 (GLOBE NEWSWIRE) — YYFORCE Inc. (NASDAQ: YFOR)

Inveniam Introduces Proof of Illiquid Reserves

Continuous, audit-ready valuation for private credit and illiquid books—allowing outside verification down to the source page without sharing confidential documents. ABU DHABI, United Arab Emirates, Oct. 21, 2026 (GLOBE NEWSWIRE) — Inveniam Capital Partners today introduced Proof of Illiquid Reserves, an enterprise solution enabling institutions to mark hard-to-value assets continuously

New JAHA-Published EggNest® Study and Texas State Regulatory Variance Validate Shift Toward Apron-Free Workflows in the Interventional Lab

EggNest The Christ Data Infographic MINNEAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) — Egg Medical today announced the publication of a prospective study in the Journal of the American Heart Association (JAHA) evaluating its EggNest Enhanced Radiation Protection Devices (ERPDs). Conducted at The Christ Hospital in Cincinnati, OH, the real-world clinical

YYForce AI Humanoid Housekeepers to be trained in Novotel Hotel

Acquires 20 wearable data collection systems to capture real-world housekeeping tasks to support robot learning and development SINGAPORE, Oct. 20, 2026 (GLOBE NEWSWIRE) — YYForce Inc. (NASDAQ: YFOR) (“YYForce” or the “Company”), a technology-enabled provider of workforce solutions, integrated facility management and commercial robotics services, today announced the acquisition of

Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials

Expands Fortrea’s early clinical development network with dedicated bioanalytical capabilities, increased clinical research unit capacity and a more integrated platform for clients Highlights Fortrea completes acquisition of the Early Phase Services division from Worldwide Clinical Trials Adds a 60,000-square-foot GLP-compliant bioanalytical laboratory in Austin, Texas; a 200-bed GCP-compliant clinical pharmacology